Barbara Tate

Barbara Tate

Venture Partner

Barbara joined DDF as a Venture Partner in 2016.

Barbara is a neuroscientist who has worked in both large and small pharmaceutical companies. She is currently the Chief Scientific Officer at the Friedreich’s Ataxia Research Alliance, a not-for-profit that is marshaling and focusing the resources and relationships needed to cure Friedreich’s Ataxia. Previously, she was Vice President and Head of Biology at Rodin Therapeutics, an Atlas Venture company, where she also consulted on other portfolio companies. Prior to Rodin, Barbara was Vice President for Research at Satori Pharmaceuticals, a biotech company developing a treatment for Alzheimer’s disease. At Pfizer, Barbara managed the neurodegenerative disease area group in Groton, CT. Prior to working in industry, Barbara was an academic researcher at Brown Medical School and Harvard Medical School.

Outside of SV, Barbara enjoys long distance running with family and friends, as well as her riding her horses and playing with grandkids.

Academic Credentials
BA in Biology, a PhD in Physiology, and was a postdoctoral fellow at Harvard Medical School


Fill in the form and will be in touch with you shortly.

Google reCaptcha: Invalid site key.

Why a form?
Your message is important to us so thank you for filling in our form – it will be received by the intended recipient and you will receive a reply via email. We’ve introduced a form to better protect our team from website scraping generated spam but hope that real people with real messages will still take the time to complete it.